Total Payments
$9,161
2024 Payments
$132.15
Companies
38
Transactions
614
Medicare Patients
4,519
Medicare Billing
$578,202
Payment Breakdown by Category
Food & Beverage$9,048 (98.8%)
Gifts$59.40 (0.6%)
Education$53.65 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,048 | 605 | 98.8% |
| Gift | $59.40 | 1 | 0.6% |
| Education | $53.65 | 8 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,716 | 130 | $0 (2023) |
| Novo Nordisk Inc | $1,160 | 95 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $926.93 | 60 | $0 (2023) |
| Amgen Inc. | $797.66 | 55 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $737.12 | 46 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $616.47 | 34 | $0 (2023) |
| Radius Health, Inc. | $398.32 | 23 | $0 (2023) |
| ABBVIE INC. | $383.32 | 24 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $364.40 | 23 | $0 (2023) |
| Tandem Diabetes Care, Inc. | $171.36 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $132.15 | 7 | ABBVIE INC. ($64.71) |
| 2023 | $409.06 | 22 | Lilly USA, LLC ($132.69) |
| 2022 | $1,721 | 97 | Lilly USA, LLC ($289.10) |
| 2021 | $1,075 | 65 | Lilly USA, LLC ($238.86) |
| 2020 | $708.34 | 42 | Lilly USA, LLC ($151.12) |
| 2019 | $1,703 | 121 | Lilly USA, LLC ($283.03) |
| 2018 | $1,443 | 108 | Lilly USA, LLC ($298.33) |
| 2017 | $1,969 | 152 | Novo Nordisk Inc ($395.64) |
All Payment Transactions
614 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $16.06 | General |
| 07/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/29/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Endocrinology | ||||||
| 03/14/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $13.76 | General |
| 02/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Diabetes Care | ||||||
| 01/31/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $8.15 | General |
| Category: Diabetes | ||||||
| 11/09/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Bone Health | ||||||
| 05/15/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Neuromodulation | ||||||
| 03/29/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Diabetes | ||||||
| 03/28/2023 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/22/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: DIABETES | ||||||
| 03/21/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Bone Health | ||||||
| 03/14/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Endocrinology | ||||||
| 03/08/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Diabetes | ||||||
| 02/27/2023 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/22/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Diabetes | ||||||
| 02/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/20/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Diabetes | ||||||
| 02/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Diabetes | ||||||
| 02/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $5.34 | General |
| Category: Diabetes | ||||||
| 01/25/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Bone Health | ||||||
| 01/23/2023 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 01/11/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 580 | 2,180 | $124,995 | $48,238 |
| 2022 | 21 | 1,277 | 7,126 | $401,891 | $152,851 |
| 2021 | 20 | 1,282 | 9,386 | $512,813 | $192,520 |
| 2020 | 17 | 1,380 | 9,728 | $538,005 | $184,594 |
Total Patients
4,519
Total Services
28,420
Medicare Billing
$578,202
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 22 | 1,560 | $63,360 | $28,043 | 44.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 169 | $36,318 | $12,143 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $8,850 | $3,773 | 42.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 53 | 59 | $4,273 | $971.14 | 22.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 32 | 32 | $3,290 | $899.31 | 27.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 83 | 88 | $792.00 | $722.40 | 91.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 46 | 49 | $2,042 | $466.48 | 22.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 32 | $2,024 | $318.30 | 15.7% |
| 82565 | Blood creatinine level | Office | 2023 | 59 | 64 | $1,428 | $316.26 | 22.1% |
| 82040 | Albumin (protein) level | Office | 2023 | 41 | 44 | $944.00 | $208.55 | 22.1% |
| 82310 | Calcium level, total | Office | 2023 | 36 | 39 | $870.00 | $192.28 | 22.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 14 | 14 | $804.00 | $183.68 | 22.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 64 | 5,340 | $234,960 | $91,093 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 240 | 437 | $90,022 | $39,497 | 43.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 45 | $12,510 | $5,938 | 47.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $8,320 | $2,726 | 32.8% |
| 82306 | Vitamin d-3 level | Office | 2022 | 76 | 84 | $9,660 | $2,456 | 25.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 93 | 138 | $9,798 | $2,289 | 23.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $4,776 | $1,735 | 36.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 75 | 124 | $5,084 | $1,189 | 23.4% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2022 | 23 | 24 | $4,200 | $982.03 | 23.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 189 | 318 | $2,862 | $942.57 | 32.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 66 | 91 | $6,370 | $938.86 | 14.7% |
| 82565 | Blood creatinine level | Office | 2022 | 102 | 140 | $3,080 | $707.80 | 23.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 37 | 45 | $2,025 | $469.80 | 23.2% |
About Dr. Farheen Yousuf, MD
Dr. Farheen Yousuf, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912108366.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Farheen Yousuf, MD has received a total of $9,161 in payments from pharmaceutical and medical device companies, with $132.15 received in 2024. These payments were reported across 614 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($9,048).
As a Medicare-enrolled provider, Yousuf has provided services to 4,519 Medicare beneficiaries, totaling 28,420 services with total Medicare billing of $578,202. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Austin, TX
- Active Since 05/31/2007
- Last Updated 04/15/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1912108366
Products in Payments
- JARDIANCE (Drug) $783.41
- FARXIGA (Drug) $616.47
- TRADJENTA (Drug) $506.96
- TRULICITY (Drug) $450.04
- EVENITY (Biological) $420.99
- Ozempic (Drug) $406.97
- UNITHROID (Drug) $402.76
- Tymlos (Biological) $350.33
- HUMULIN (Drug) $331.31
- Victoza (Drug) $302.84
- Saxenda (Drug) $298.64
- TOUJEO (Drug) $288.59
- Prolia (Biological) $268.35
- TOUJEO (Biological) $267.73
- BAQSIMI (Drug) $244.92
- INVOKANA (Drug) $204.06
- MOUNJARO (Drug) $172.30
- Kerendia (Drug) $154.70
- Vascepa (Drug) $139.92
- AFREZZA (Drug) $132.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Austin
Dr. Thomas Blevins, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.5M
Endocrinology, Diabetes & Metabolism $1.5M
Michele Mcdermott, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $137,974
Endocrinology, Diabetes & Metabolism $137,974
Tira Chaicha-Brom, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $56,872
Endocrinology, Diabetes & Metabolism $56,872
Dr. Simona Scumpia, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $52,573
Endocrinology, Diabetes & Metabolism $52,573
Dr. Padma Horvit, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $20,822
Endocrinology, Diabetes & Metabolism $20,822
Luis Casaubon, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $8,976
Endocrinology, Diabetes & Metabolism $8,976